Using Herceptin together with another powerful breast cancer drug before surgery could shrink or destroy tumours in just 11 days, a study has found.
Around a quarter of women given a combined treatment of drugs in a clinical study saw their tumours shrink or disappear. Some patients may be spared chemotherapy if they are given a combination of the drugs Tyverb (lapatinib) and Herceptin (trastuzumab) immediately after diagnosis, according to the research by a team of British doctors.
The medics, who presented their study to experts at the European Breast Cancer Conference in Amsterdam, said their findings had “groundbreaking potential”. Some 257 women with an aggressive form of cancer – HER2 – were involved in the clinical trial and either received no treatment, one of the drugs or a combination of them.
Around a quarter of the women on the combined treatment saw their tumours shrink or disappear.
Click on the link to read more